The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|October 2, 2013
- Pharmaceutical Technology-10-02-2013
- Volume 37
- Issue 10
Video Capture and Synchronisation System
Video Capture and Synchronisation System
A video system provides texture analysis data and analysis capabilities for pharmaceutical and supplement manufacturers. The Video Capture and Synchronisation System can record tests and replay them frame by frame simultaneously with their corresponding force-distance-time graphs. The system includes a moveable video camera, a transparent test platform, and an optional light attachment. To conduct a test, the camera is positioned in the most appropriate location for testing. As the TA.XT plus texture analyser begins collecting data, a signal is relayed to the Video Capture Interface, which initiates recording at up to 50 frames per second. Data is collected and analyzed by Exponent Stable Micro Systems’ proprietary software.
Articles in this issue
about 13 years ago
Q&A with Amie Gehris, Dow Water and Process Solutionsabout 13 years ago
Unraveling the Mystery of Ireland's Pharm-Attractionsabout 13 years ago
Report from: Middle East and North Africaabout 13 years ago
Maintaining and Verifying the Cold Chainabout 13 years ago
Ensuring Compliance with Drug Accountability Requirementsabout 13 years ago
The Expense of Vision in Outsourcingabout 13 years ago
LCMS-8050 Mass Spectrometer Increases Quality Analysisabout 13 years ago
Tracking Quality in Drug Manufacturingabout 13 years ago
USP Seeks Input on Standards for Plastic Packaging Systemsabout 13 years ago
RheocalcT Software Tests Parameters and Data CollectionRelated to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Trending on Pharmaceutical Technology
1
Why AI Model Updates Need Change Control: AAPS PharmSci 360 2026
2
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
3
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
4
AI Formulation: Regulators Want Data
5